PATENT CLAIM ANALYSIS

Application Number: 16346215
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to a novel protein formulation. In particular, the invention relates to a liquid pharmaceutical composition of tocilizumab, a method of manufacturing the composition, a kit including the composition, a package including the composition and to methods of treatment using the composition and/or package.

Claim (Index 5):
The liquid pharmaceutical composition according to  claim 1 , wherein the surfactant is a polysorbate.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.82759
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15313480', '13766966', '11293322', '14379095', '15866154']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7150287058485519
- 35 USC 102 Novelty (BERT): 0.4856338708952
- Combined Prediction Score: 0.6920892223532168
- Mean Citation Score: 197.14773
- Max Citation Score: 204.777
- Similarity Product: 153.34491050255298

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test